YAU-25017-35007
1 vaccination
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 237 / VA
- Registered
- 2021-08-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-05
Dose 1 — Janssen/Johnson & Johnson
-
2021-08-06
Registered in v-safe
-
2021-08-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-08-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-08-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-08-19
Survey response — day 14, dose 1MedDRA: Migraine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-16
- 2021-11-06
- 2022-02-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-05 | Janssen/Johnson & Johnson | No |
Free text
Release 9 — day 14, dose 1
Symptoms: Migraine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release